Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression

Increasing evidence indicates that the host immune response has a monumental role in the etiology of major depressive disorder (MDD), motivating the development of the inflammatory hypothesis of depression. Central to the involvement of chronic inflammation in MDD is a wide range of signaling defici...

Full description

Bibliographic Details
Main Authors: Ryan T. McCallum, Melissa L. Perreault
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/9/2270
_version_ 1797519902985158656
author Ryan T. McCallum
Melissa L. Perreault
author_facet Ryan T. McCallum
Melissa L. Perreault
author_sort Ryan T. McCallum
collection DOAJ
description Increasing evidence indicates that the host immune response has a monumental role in the etiology of major depressive disorder (MDD), motivating the development of the inflammatory hypothesis of depression. Central to the involvement of chronic inflammation in MDD is a wide range of signaling deficits induced by the excessive secretion of pro-inflammatory cytokines and imbalanced T cell differentiation. Such signaling deficits include the glutamatergic, cholinergic, insulin, and neurotrophin systems, which work in concert to initiate and advance the neuropathology. Fundamental to the communication between such systems is the protein kinase glycogen synthase kinase-3 (GSK-3), a multifaceted protein critically linked to the etiology of MDD and an emerging target to treat pathogenic inflammation. Here, a consolidated overview of the widespread multi-system involvement of GSK-3 in contributing to the neuropathology of MDD will be discussed, with the feed-forward mechanistic links between all major neuronal signaling pathways highlighted.
first_indexed 2024-03-10T07:49:22Z
format Article
id doaj.art-7517609c3351420c9a5ed2e3327b59b7
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T07:49:22Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-7517609c3351420c9a5ed2e3327b59b72023-11-22T12:23:29ZengMDPI AGCells2073-44092021-09-01109227010.3390/cells10092270Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in DepressionRyan T. McCallum0Melissa L. Perreault1Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, CanadaDepartment of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, CanadaIncreasing evidence indicates that the host immune response has a monumental role in the etiology of major depressive disorder (MDD), motivating the development of the inflammatory hypothesis of depression. Central to the involvement of chronic inflammation in MDD is a wide range of signaling deficits induced by the excessive secretion of pro-inflammatory cytokines and imbalanced T cell differentiation. Such signaling deficits include the glutamatergic, cholinergic, insulin, and neurotrophin systems, which work in concert to initiate and advance the neuropathology. Fundamental to the communication between such systems is the protein kinase glycogen synthase kinase-3 (GSK-3), a multifaceted protein critically linked to the etiology of MDD and an emerging target to treat pathogenic inflammation. Here, a consolidated overview of the widespread multi-system involvement of GSK-3 in contributing to the neuropathology of MDD will be discussed, with the feed-forward mechanistic links between all major neuronal signaling pathways highlighted.https://www.mdpi.com/2073-4409/10/9/2270MDDdepressionglycogen synthase kinase 3inflammationoxidative stress
spellingShingle Ryan T. McCallum
Melissa L. Perreault
Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
Cells
MDD
depression
glycogen synthase kinase 3
inflammation
oxidative stress
title Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
title_full Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
title_fullStr Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
title_full_unstemmed Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
title_short Glycogen Synthase Kinase-3: A Focal Point for Advancing Pathogenic Inflammation in Depression
title_sort glycogen synthase kinase 3 a focal point for advancing pathogenic inflammation in depression
topic MDD
depression
glycogen synthase kinase 3
inflammation
oxidative stress
url https://www.mdpi.com/2073-4409/10/9/2270
work_keys_str_mv AT ryantmccallum glycogensynthasekinase3afocalpointforadvancingpathogenicinflammationindepression
AT melissalperreault glycogensynthasekinase3afocalpointforadvancingpathogenicinflammationindepression